Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Horizon Discovery Group plc    HZD   GB00BK8FL363

HORIZON DISCOVERY GROUP PLC

(HZD)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
10/11/2019 10/14/2019 10/15/2019 10/16/2019 10/17/2019 Date
159.7(c) 156.2(c) 155.2(c) 158.5(c) 160 Last
726 906 155 884 37 856 49 804 63 895 Volume
+6.47% -2.19% -0.64% +2.13% +0.95% Change
More quotes
Financials (GBP)
Sales 2019 64,2 M
EBIT 2019 -7,73 M
Net income 2019 -3,96 M
Finance 2019 18,1 M
Yield 2019 -
Sales 2020 70,9 M
EBIT 2020 -5,66 M
Net income 2020 -3,03 M
Finance 2020 15,5 M
Yield 2020 -
P/E ratio 2019 -62,3x
P/E ratio 2020 -56,3x
EV / Sales2019 3,43x
EV / Sales2020 3,14x
Capitalization 238 M
More Financials
Company
Horizon Discovery Group plc is a United Kingdom-based life science company. The Company uses gene editing and gene modulation application. Through the application of these technologies the Company enables researchers to alter almost any gene or modulate its function in human or mammalian cells to... 
More about the company
Surperformance© ratings of Horizon Discovery Group pl
Trading Rating : Investor Rating :
More Ratings
Latest news on HORIZON DISCOVERY GROUP PL
10/04HORIZON DISCOVERY : Second Price Monitoring Extn
PU
10/04HORIZON DISCOVERY : Price Monitoring Extension
PU
09/30HORIZON DISCOVERY : Signs License Agreement With Glenmark Pharmaceuticals for GS..
BU
09/16HORIZON DISCOVERY GROUP PLC : Results for the Six Months Ended 30 June 2019
AQ
08/12HORIZON DISCOVERY : Second Price Monitoring Extn
PU
08/05HORIZON DISCOVERY : SMARTvector shRNA technology deployed in Celyad's successful..
PU
07/08HORIZON DISCOVERY : 's SMARTvector shRNA Technology Deployed in Celyad's Success..
BU
07/08HORIZON DISCOVERY : SMARTvector platform supports Celyad IND filing
PU
07/05HORIZON DISCOVERY : Director/PDMR Shareholding
PU
05/21HORIZON DISCOVERY : Annual Report and Notice of Annual General Meeting
PU
04/29HORIZON DISCOVERY : Full Year Results for Year Ending 31 December 2018
PU
03/25HORIZON DISCOVERY : to collaborate with St George's University Hospital and EMQN..
PU
03/20HORIZON DISCOVERY : Notice of Full Year Results
PU
03/19CELYAD : - Celyad :'s 2019 R&D Day Highlights shRNA Platform and Pipeline of Nex..
AQ
01/28HORIZON DISCOVERY : and Rutgers University Form Exclusive Partnership to Develop..
BU
More news
News in other languages on HORIZON DISCOVERY GROUP PL
2018HORIZON DISCOVERY GROUP PLC : publication des résultats semestriels
2018HORIZON DISCOVERY GROUP PLC : Veröffentlichung des Halbjahresergebnisses
2018HORIZON DISCOVERY GROUP PLC : Veröffentlichung des Jahresergebnisses
2018HORIZON DISCOVERY GROUP PLC : publication des résultats annuels
2017HORIZON DISCOVERY GROUP PLC : Veröffentlichung des Halbjahresergebnisses
More news
Analyst Recommendations on HORIZON DISCOVERY GROUP PL
More recommendations
Sector news : Biotechnology & Medical Research - NEC
08:29aGLOBAL MARKETS LIVE : Nestlé, Netflix, Huawei, General Motors…
10/16INCYTE : Says Phase 3 REACH2 Trial Meets Endpoint
DJ
10/15New Gilead Sciences CFO Expected to Pursue More Deals to Expand Portfolio
DJ
10/15GILEAD SCIENCES : Names Andrew Dickinson Chief Financial Officer
DJ
10/10GILEAD SCIENCES : Galapagos See Efficacy in Advanced Rheumatoid Arthritis Study
DJ
More sector news : Biotechnology & Medical Research - NEC
Chart HORIZON DISCOVERY GROUP PLC
Duration : Period :
Horizon Discovery Group plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HORIZON DISCOVERY GROUP PL
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 204,67  GBp
Last Close Price 158,50  GBp
Spread / Highest target 76,7%
Spread / Average Target 29,1%
Spread / Lowest Target -9,15%
EPS Revisions
Managers
NameTitle
Terrence William Pizzie Chief Executive Officer & Executive Director
Ian David Gilham Executive Chairman
Kim Nichols Head-Global Operations
Jayesh Pankhania Chief Financial Officer & Director
Jonathan D. Moore Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
HORIZON DISCOVERY GROUP PLC-9.43%306
IQVIA HOLDINGS INC.24.67%28 371
LONZA GROUP32.94%25 332
CELLTRION, INC.--.--%20 127
INCYTE CORPORATION22.85%16 801
SEATTLE GENETICS, INC.48.01%14 251